Hims & Hers Announces Acquisition of At-Home Lab Testing Facility to Improve Affordable Whole Body Testing

Gunderson Dettmer advised Hims & Hers in the acquisition of Sigmund NJ LLC, dba Trybe Labs, to expand its capabilities with at-home lab testing. This acquisition will enhance Hims & Hers’ ability to deliver personalized health solutions by supporting at-home blood draws and comprehensive whole-body testing. The move also accelerates the company’s expansion into high-impact clinical categories such as low testosterone and perimenopausal and menopausal support, further solidifying its position as a leader in personalized wellness.

In the announcement of the acquisition, Chief Medical Officer of Hims & Hers Dr. Patrick Carroll said, “The healthcare that customers expect and deserve today is on-demand care with treatments designed specifically for them. This next generation of healthcare is what we’re building at Hims & Hers by providing the best information and set of options to each customer that comes to our platform so they can access precisely the care that is best for them. Access to richer data allows us to deepen the insights that providers can use on our platform to guide their clinical decisions for each individual patient. At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect.”

The Gunderson deal team was co-led by public companies partner Alexa Belonick and M&A partner David Moore and included public companies associate Elena Vespoli and corporate associates Amy Luong and Emma Anderson, strategic transactions and licensing partner Gina Marek and associates Cameron Jahansouz and Maddy Kerr Hyde, executive compensation partner Sharon Hendricks and associate Elisabeth Bernabe, employment and labor partner Natalie Pierce and tax partner Jaime Narayan.

Companies
Hims & Hers
Trybe Labs